Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcus Biosciences Inc RCUS

Healthcare Biotechnology
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical... see more

Recent & Breaking News (NYSE:RCUS)

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire January 12, 2021

Arcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI Symposium

Business Wire January 11, 2021

Arcus Biosciences Appoints Biotech Industry Veteran, Andrew Perlman, M.D., Ph.D. and Gilead's SVP of Research Biology, Michael Quigley, Ph.D. to Its Board of Directors

Business Wire January 6, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire December 10, 2020

Arcus Biosciences Expands Strategic Relationship with WuXi Biologics to Develop a Best-in-Class anti-CD39 Antibody for the Treatment of Cancer

Business Wire December 9, 2020

Arcus Biosciences to Participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference

Business Wire November 18, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire November 10, 2020

Arcus Biosciences Announces Third Quarter 2020 Financial Results and Corporate Updates

Business Wire November 5, 2020

Arcus to Collaborate With AstraZeneca on Registrational Trial for Domvanalimab, Arcus's Novel Anti-TIGIT Antibody, Plus Imfinzi® in Stage III NSCLC

Business Wire October 29, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire October 8, 2020

Jennifer Jarrett Returns to Arcus Biosciences as Chief Operating Officer

Business Wire October 1, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire September 10, 2020

Arcus Biosciences to Participate in Upcoming September 2020 Investor Conferences

Business Wire August 27, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire August 11, 2020

Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates

Business Wire August 6, 2020

Arcus Biosciences Announces New Employment Inducement Grant

Business Wire August 4, 2020

Arcus Biosciences to Participate in Upcoming August Investor Conferences

Business Wire July 28, 2020

Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies

Business Wire July 13, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire July 9, 2020

Bob Goeltz to Join Arcus Biosciences as Chief Financial Officer

Business Wire July 7, 2020